Form 4 for BIIB Biogen
Accepted 2023-07-05 00:00:00 ET · period of report 2023-06-30 · accession 0001127602-23-020236 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-05 | 2023-06-30 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | +252 | 4,096 | +7% | $0 |
| D | 2023-07-05 | 2023-06-30 | BIIB | Kramer Robin | CAO | F - Tax | $284.85 | -122 | 3,974 | -3% | -$34.8K |
| D | 2023-07-05 | 2023-06-30 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | -252 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-30 | M | A | 252 | $0.00 | 4,095.75 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-30 | F | D | 122 | $284.85 | 3,973.75 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2023-06-30 | M | D | 252 | $0.00 | 0 | D | $0.00 · — to 2023-07-01 | 252 Common Stock | (F1) The restricted stock units vested in three (3) equal annual installments commencing one year after the grant date of 07/01/2020. |